42
report
Learning from COVID-19: Reimagining Public-Private Partnerships in Public Health
The Milken Institute Center for Public Health leveraged our network of thought leaders to maximize
learnings from the COVID-19 pandemic, focused on examining the private sector’s role and responsibility in supp
+ Read More
report
Strengthening the Biomedical Innovation Ecosystem: A Scorecard for System Assessment
As patients, we often evaluate our interactions within the "system" of biomedical innovation with a
simple question: "Did it work for me?" This evaluation considers many issues, including whether the best treatments are accessible and available, how the
+ Read More
report
Cell and Gene Therapies: Looking Ahead to 2022
Cell and gene therapies are a new category of medicines transforming how we treat and potentially c
ure disease. Both cell and gene therapies seek to modify genetic material to fight disease.
+ Read More
report
The Emergence of New Monies and the Need to Prepare the Financial System for the Digital Age
Digitalisation is a revolution in the world of money and payments. Technological and social transfo
rmations are disrupting the status quo.
+ Read More
report
Ensuring ESG Impact: Four Actionable Recommendations for a Dependable Path | Milken Institute
With Environmental, Social and Governance (ESG) investing becoming mainstream, it is urgent to deve
lop a standardised set of information that investors and companies can use in their decision-making process.
+ Read More
report
Policy Issue Brief: A Call to Action for Diversity in Clinical Trials
FasterCures has initiated a body of work to advance system change within biomedical research to foc
us on and value diversity and representation within clinical trials.
+ Read More
report
Roadmap for Investment in Dementia Care
On average, people with Alzheimer’s disease and frontotemporal dementia live six to ten years after
diagnosis. People with vascular dementia and Lewy body dementia live on average five to six years after diagnosis.
+ Read More
report
A Global Early Warning System for Pandemics: A Blueprint for Coordination
The COVID-19 pandemic has had enormous health, social, and economic consequences.
report
Models for Financing Antibiotic Development to Address Antimicrobial Resistance
The Financial Innovations Labs® and FasterCures teams have collaborated on a project to id
report
ESG Investing: Beyond the Standards
In the face of increased pressure from investors for information and the complexity of disclosing t
he relevant data, the public and private sectors agree on the need to simplify environmental, social and governance (ESG) reporting.
+ Read More
report
Understanding and Identifying Gaps in Employer Mental Health Resources
About 60 million Americans live with mental health conditions, and nearly half of those go without
treatment. The COVID-19 pandemic widened the gap between employers and employees on mental health in the workplace.
+ Read More
report
A Global Early Warning System for Pandemics: Perspectives from the Front Lines
The COVID-19 pandemic exposed critical gaps in the world’s ability to detect, track, and analyze pa
ndemic threats.
+ Read More